Yuanting Gu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 4
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Co-authors
- Mingli Han (6 shared papers)Xin Ge (4 shared papers)Nan Wang (12 shared papers)Dongwei Dou (4 shared papers)Youyi Xiong (10 shared papers)Xiaodong Xu (3 shared papers)Lin Li (3 shared papers)Fang Wang (6 shared papers)
In The Last Decade
Yuanting Gu
21 papers receiving 713 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 348
- Molecular Biology 490
- Oncology 112
- Geriatrics and Gerontology 7
- Complementary and alternative medicine 14
Countries citing papers authored by Yuanting Gu
This map shows the geographic impact of Yuanting Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanting Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanting Gu more than expected).
Fields of papers citing papers by Yuanting Gu
This network shows the impact of papers produced by Yuanting Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanting Gu. The network helps show where Yuanting Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuanting Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 163 | |
| 2 | 2020 | 81 | |
| 3 | 2018 | 64 | |
| 4 | 2020 | 56 | |
| 5 | 2020 | 45 | |
| 6 | Antitumor effects of crocin on human breast cancer cells. | 2015 | 39 |
| 7 | 2021 | 37 | |
| 8 | 2018 | 36 | |
| 9 | 2015 | 35 | |
| 10 | 2018 | 33 | |
| 11 | 2020 | 31 | |
| 12 | 2019 | 29 | |
| 13 | 2021 | 24 | |
| 14 | 2022 | 11 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2021 | 3 |
About Yuanting Gu
Yuanting Gu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 22 papers that have together received 716 indexed citations. Recurring topics across this work include Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (2 papers), DNA Repair Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Cancer Research (348 citations), Molecular Biology (490 citations), Oncology (112 citations), Geriatrics and Gerontology (7 citations) and Complementary and alternative medicine (14 citations). Yuanting Gu has collaborated with scholars based in China, Australia and Russia. Frequent co-authors include Mingli Han, Xin Ge, Nan Wang, Dongwei Dou, Youyi Xiong, Xiaodong Xu, Lin Li, Fang Wang, Xiaoyang Ren and Xinguang Qiu. Their work appears in journals such as Cancer Cell International, Journal of Biomedical Science, Archives of Biochemistry and Biophysics, OncoTargets and Therapy and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.